EE73 Ocean (OP-103): Patients with Relapsed/Refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone or Pomalidomide Plus Dexamethasone - a Resource Utilization Analysis of Adverse Events Leading to Hospitalizations
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.345
https://www.valueinhealthjournal.com/article/S1098-3015(23)03475-7/fulltext
Title :
EE73 Ocean (OP-103): Patients with Relapsed/Refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone or Pomalidomide Plus Dexamethasone - a Resource Utilization Analysis of Adverse Events Leading to Hospitalizations
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03475-7&doi=10.1016/j.jval.2023.09.345
First page :
Section Title :
Open access? :
No
Section Order :
12369